Exosome-SARS-CoV-2 mRNA Vaccine (Capricor Therapeutics)

N/A

Report date: 2025/08/25 11:50:53

Base Information

Drug NameExosome-SARS-CoV-2 mRNA Vaccine (Capricor Therapeutics)
Drug Alias NameExosome-mRNA COVID-2019 vaccine (Capricor Therapeutics)Tripartite exosome-mRNA vaccine (Capricor Therapeutics)Exosome mRNA vaccine (COVID-19)(Capricor)exosome-mRNA vaccine for SARS-CoV-2(Capricor)StealthX +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineBiologics > Exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCapricor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCapricor Therapeutics IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Inactive CompaniesNational Institutes Of Health
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A